A detailed history of Intellectus Partners, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Intellectus Partners, LLC holds 8,884 shares of NVO stock, worth $776,195. This represents 0.28% of its overall portfolio holdings.

Number of Shares
8,884
Previous 8,135 9.21%
Holding current value
$776,195
Previous $1.16 Million 8.96%
% of portfolio
0.28%
Previous 0.32%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$119.07 - $145.42 $89,183 - $108,919
749 Added 9.21%
8,884 $1.06 Million
Q2 2024

Jul 18, 2024

SELL
$122.71 - $146.91 $24,542 - $29,382
-200 Reduced 2.4%
8,135 $1.16 Million
Q1 2024

May 03, 2024

BUY
$102.11 - $135.92 $6,637 - $8,834
65 Added 0.79%
8,335 $1.07 Million
Q4 2023

Feb 05, 2024

BUY
$87.78 - $105.45 $74,437 - $89,421
848 Added 11.43%
8,270 $855,000
Q3 2023

Oct 25, 2023

BUY
$90.94 - $199.54 $674,956 - $1.48 Million
7,422 New
7,422 $674,000
Q2 2019

Aug 08, 2019

SELL
$46.79 - $52.47 $2,620 - $2,938
-56 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$46.36 - $52.63 $2,596 - $2,947
56 New
56 $3,000
Q4 2018

Feb 14, 2019

BUY
$41.54 - $47.25 $0 - $0
0 New
0 $0

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Intellectus Partners, LLC Portfolio

Follow Intellectus Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intellectus Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intellectus Partners, LLC with notifications on news.